AAAAAA

   
Results: 1-5 |
Results: 5

Authors: Fountzilas, G Tsavdaridis, D Kalogera-Fountzila, A Christodoulou, C Timotheadou, E Kalofonos, C Kosmidis, P Adamou, A Papakostas, P Gogas, H Stathopoulos, G Razis, E Bafaloukos, D Skarlos, D
Citation: G. Fountzilas et al., Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase IIstudy, ANN ONCOL, 12(11), 2001, pp. 1545-1551

Authors: Kakolyris, S Papadakis, E Tsiafaki, X Kalofonos, C Rapti, A Toubis, M Bania, E Kouroussis, C Chainis, K Androulakis, N Agelaki, S Sarra, E Vardakis, N Georgoulias, V
Citation: S. Kakolyris et al., Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study, LUNG CANC, 32(2), 2001, pp. 179-187

Authors: Nicolaides, C Dimopoulos, MA Samantas, E Bafaloukos, D Kalofonos, C Fountzilas, G Razi, E Kosmidis, P Pavlidis, N
Citation: C. Nicolaides et al., Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 11(7), 2000, pp. 873-875

Authors: Skarlos, DV Samantas, E Pectasides, D Pavlidis, N Kalofonos, C Klouvas, G Panoussaki, E Tsiakopoulos, E Poulakis, N Fountzilas, G
Citation: Dv. Skarlos et al., Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis - A study of the Hellenic Cooperative Oncology Group, AM J CL ONC, 22(1), 1999, pp. 87-93

Authors: Pectasides, D Aravantinos, G Visvikis, A Bakoyiannis, C Halikia, A Kalofonos, C Kosmidis, P Skarlos, D Fountzilas, G
Citation: D. Pectasides et al., Platinum-based chemotherapy of primary extragonadal germ cell tumours: TheHellenic Cooperative Oncology Group experience, ONCOL-BASEL, 57(1), 1999, pp. 1-9
Risultati: 1-5 |